Overview
A Study of Gaboxadol in Primary Insomnia
Status:
Completed
Completed
Trial end date:
2005-11-01
2005-11-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
To evaluate the efficacy safety and tolerability of gaboxadol in primary insomnia.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
H. Lundbeck A/STreatments:
Gaboxadol
Criteria
Inclusion Criteria:- patients with a diagnosis of primary insomnia